Michaela Liedtke MD in Stanford, California

Home California Stanford

Michaela Liedtke MD has Hematology as her primary medical specialty. Their primary office is: 300 Pasteur Dr in Stanford, California.

They're a part of the: Stanford Health Care medical group which has around 2,603 members. You can call their office at 650-723-4000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1994 (around 30 years of experience). They are listed as doing telehealth appointments.

Michaela Liedtke MD Office Phone and Directions

Michaela Liedtke MD
Stanford Health Care
300 Pasteur Dr
Stanford, California 94305
650-723-4000

Patient Ratings
Please rate your experience with Michaela Liedtke MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 650-723-4000

Enter a starting address:

Healthcare Info for Michaela Liedtke MD

Additional Medical Specialties Include:
INTERNAL MEDICINE, MEDICAL ONCOLOGY

Medical School: Sorry, her university is not listed
Graduation Year: 1994
The Primary Medical Specialty for Michaela Liedtke MD is listed as: Hematology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 30
PAC (PECOS ID)#: 7315972791
NPI #: 1609918556
NPI Created On: 02/13/2007
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207RH0000X
License Number:
A86006
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, German.

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, more than 30 minutes
Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $1,768

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788481459

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $2,525

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788481457

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $1,950

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801632097

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 820049717

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ICLUSIG

Open Associated Drug #1: 63020-535-30

Payments Total: $3,960

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 820049713

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: EXKIVITY

Open Associated Drug #1: 63020-040-90

Payments Total: $1,700

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: ;KP30312;KPSCIM;10621467

Record ID:: 844417103

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CELLT

Name of Drug #1: Tecartus

Open Associated Drug #1: 71287-219-02